Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX
LAV Fund VI, L.P. converted 11,550,917 Adarx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 28, 2026 · Filed Sep 29, 2026
On Sep 28, 2026, LAV Fund VI, L.P. (10% owner) converted 11,550,917 Adarx Pharmaceuticals, Inc. shares, leaving 307,738 shares. Filed Sep 29, 2026 (Form 4).
- Converted
- 11,550,917 shares
- Holding after
- 307,738 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock | Conversion | 8,908,775 | 8,908,775 | Direct | |
| Sep 28, 2026 | Common Stock | Conversion | 1,667,469 | 10,576,244 | Direct | |
| Sep 28, 2026 | Common Stock | Conversion | 513,067 | 11,089,311 | Direct | |
| Sep 28, 2026 | Common Stock | Conversion | 153,868 | 11,243,179 | Direct | |
| Sep 28, 2026 | Common Stock | Conversion | 307,738 | 307,738 | Indirect |
Source
Related
- Adarx Pharmaceuticals, Inc.
- LAV Fund VI, L.P.
- Adarx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Chimovits Erez · Sep 30, 2026